Stay updated on ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer
Sign up to get notified when there's something new on the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page.

Latest updates to the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page
- CheckyesterdayChange DetectedThe page now displays Revision: v3.5.4, replacing the previous revision. This reflects a new release version for the study history page.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA UI/version update is reflected on the page (revision moved from v3.5.2 to v3.5.3), without any corresponding changes to the clinical trial’s recorded information.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision: v3.5.2 was added to the history, replacing Revision: v3.5.0.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded a new Revision: v3.5.0 to the record history and removed Revision: v3.4.3.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page shows a new site revision tag (v3.4.3) and removes the previous v3.4.2 tag.SummaryDifference0.1%

- Check94 days agoChange DetectedNew revision entry v3.4.2 was added to the study history. The deletions remove a government funding notice and the earlier revision v3.4.1; these are administrative history updates and do not affect study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page.